Genmab — Januar 2019
-
I didn't realize ADCT-601 which we discussed last week was with BerGenBio http://news.cision.com/bergenbio-asa/r/bergenbio-announces-start-of-phase-i-trial-evaluating-adct-601--a-novel-anti-axl-adc--in-patients-wi,c2722022?utm_source=dlvr.it&utm_medium=twitter
-
Mon JNJ informere status på MAIA og potentielt 1st line Darzalex salg for 2019. 2018 Darzalex salg er vel rimlig uinteressandte for vi forventer vel at Q4 bliver en tand bedre end Q3 2018 og den forbedring er vel mere eller mindre nem at beregne +/- 50 mil
-
Et hurtigt check på PE med dagens kurs siger 34. Totalt latterligt for en mega vækstaktie som Genmab. Man skulle jo nærmest tro markedet tror Darzalex kommer til at floppe. Men alle Anal ytikerne siger jo samtidig casen 10bn usd peaksales er intakt
-
Når i nu ved det, prøv så at overveje hvor stort et drivanker den valgte strategi egentlig er på kursen/værdiskabelsen....
-
Tro, håb og kærlighed er godt. Bare man er klar over, at det er brillerne man kigger igennem
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

